Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2746.00 | 2605.75 | 1.0538 | 1.0456 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 1250.00 | 520.59 | 2901.00 | 2605.75 | 1.1133 | 1.0946 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 3014.00 | 2605.75 | 1.1567 | 1.1293 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 1250.00 | 520.59 | 3400.00 | 2605.75 | 1.3048 | 1.2426 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2999.00 | 2605.75 | 1.1509 | 1.1247 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 2925.00 | 2605.75 | 1.1225 | 1.1020 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 1250.00 | 520.59 | 3076.00 | 2605.75 | 1.1805 | 1.1480 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2997.00 | 2605.75 | 1.1501 | 1.1241 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 3034.00 | 2605.75 | 1.1643 | 1.1354 | |
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2892.00 | 2605.75 | 1.1099 | 1.0918 |
| MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 2962.00 | 2605.75 | 1.1367 | 1.1134 |
| MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 1250.00 | 520.59 | 2950.00 | 2605.75 | 1.1321 | 1.1097 |
| MDA-MB-231 | Linsitinib | 1 | uM | 10 | 1250.00 | 520.59 | 2801.00 | 2605.75 | 1.0749 | 1.0632 |
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 2825.00 | 2605.75 | 1.0841 | 1.0708 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2852.00 | 2605.75 | 1.0945 | 1.0793 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 1250.00 | 520.59 | 1901.00 | 2605.75 | 0.7295 | 0.7462 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2848.00 | 2605.75 | 1.0930 | 1.0780 | |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2740.00 | 2605.75 | 1.0515 | 1.0437 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2894.00 | 2605.75 | 1.1106 | 1.0924 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2579.00 | 2605.75 | 0.9897 | 0.9911 | |
| MDA-MB-231 | 0 | uM | 10 | 2500.00 | 1067.09 | 4993.00 | 5130.00 | 0.9733 | 0.9762 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 1877.00 | 5130.00 | 0.3659 | 0.2831 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 2500.00 | 1067.09 | 5463.00 | 5130.00 | 1.0649 | 1.0563 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 2500.00 | 1067.09 | 4960.00 | 5130.00 | 0.9669 | 0.9705 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 2500.00 | 1067.09 | 5584.00 | 5130.00 | 1.0885 | 1.0763 |